Prytime Medical, The REBOA Company™ , proudly announces the first civilian use of its pREBOA-PRO™ catheter in the European Union, following the device's receipt of CE Mark approval.
Nonopioid vs opioid analgesics after impacted third-molar extractions- (https:linkinghub.elsevier.com/retrieve/pii/S0002817724006391) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback